Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,020 | -11,757 | -5,537 | -24,590 | -18,726 |
| Accounts payable and accrued liabilities | -194 | -1,332 | -936 | 1,013 | 2,807 |
| Other Working Capital | 1,324 | -2,026 | -2,504 | 682 | 3,841 |
| Other Operating Activity | 1,197 | 1,910 | 878 | 1,001 | -1,531 |
| Operating Cash Flow | $-16,693 | $-13,205 | $-8,099 | $-21,895 | $-13,609 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 21,427 | 19,783 | 19,783 | 26,692 | 20,491 |
| Financing Cash Flow | $21,427 | $19,783 | $19,783 | $26,692 | $20,491 |
| Beginning Cash Position | 10,552 | 10,552 | 10,552 | 5,755 | 5,755 |
| End Cash Position | 15,286 | 17,130 | 22,236 | 10,552 | 12,637 |
| Net Cash Flow | $4,735 | $6,578 | $11,684 | $4,797 | $6,882 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,693 | -13,205 | -8,099 | -21,895 | -13,609 |
| Free Cash Flow | -16,693 | -13,205 | -8,099 | -21,895 | -13,609 |